Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Compugen (CGEN) EBIT (2016 - 2025)

Compugen's EBIT history spans 17 years, with the latest figure at $56.0 million for Q4 2025.

  • On a quarterly basis, EBIT rose 848.94% to $56.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.3 million, a 310.37% increase, with the full-year FY2025 number at $31.3 million, up 310.37% from a year prior.
  • EBIT hit $56.0 million in Q4 2025 for Compugen, up from -$7.9 million in the prior quarter.
  • Over the last five years, EBIT for CGEN hit a ceiling of $56.0 million in Q4 2025 and a floor of -$30.5 million in Q2 2023.
  • Historically, EBIT has averaged -$1.4 million across 5 years, with a median of -$7.7 million in 2024.
  • The widest YoY moves for EBIT: up 848.94% in 2025, down 275.56% in 2025.
  • Tracing CGEN's EBIT over 5 years: stood at -$8.8 million in 2021, then surged by 59.81% to -$3.5 million in 2022, then skyrocketed by 609.61% to $18.0 million in 2023, then plummeted by 141.61% to -$7.5 million in 2024, then skyrocketed by 848.94% to $56.0 million in 2025.
  • Business Quant data shows EBIT for CGEN at $56.0 million in Q4 2025, -$7.9 million in Q3 2025, and -$25.2 million in Q2 2025.